hyperpigmentation, erythema and keratotic follicular papules on the cheeks and preauricular areas. This disease was first described in Japanese patients. [1] Some researchers have proposed an autosomal recessive pattern of inheritance while familial cases have been reported by others. Recently, EFFC has been believed to be a polyetiological disorder where familial and environmental factors play a role in its causation and the possibility of being a chromosomal instability syndrome. [3] The association of EFFC with atrophy has not been reported in the literature till date. Sardana et al. have reported five patients of EFFC from India. None of them had associated atrophy. [4] Similarly, Ermertcan et al. have described EFFC in two Turkish brothers having KP involving shoulders and upper arms. There was also no associated atrophy. [5] Recently Rather et al. described 14 patients of EFFC from Kashmir valley with none of them having any associated cutaneous atrophy. [6] However, in this case, the presence of atrophic scars with EFFC makes it a unique case presentation and hence reported. Whether this coexistence is merely incidental or there really has some association between the two needs more robust reports.
The relation of EFFC with KP has been a matter of debate. Some researchers suggest that EFFC to be a clinical variant of KP as there has been a frequent association with KP on the arms and overlap with ulerythema ophryogenes has also been reported. [7] However, EFFC is differentiated from KP by the presence of pigmentation and extension onto the neck. EFFC with atrophy needs to be differentiated from two other related disorders where keratotic papules occur with atrophic scars. In ulerythema ophryogenes, there is prominent facial erythema with the involvement of scalp and eyebrows. [7] However, in our case eyebrows and scalp were normal. Atrophoderma vermiculatum affects the cheeks and preauricular regions and is characterized Sir, Erythromelanosis follicularis faciei et colli (EFFC) is a rare disorder of unknown etiology characterized by erythema, hyperpigmentation and follicular plugging on the face. [1] By 2013, some 55 cases of the disease have been reported.
[2] Although atrophy has been mentioned in keratosis pilaris (KP), atrophic scars in EFFC have rarely been reported. In this article, a case of EFFC with atrophic scars is described.
A 15-year-old boy, product of nonconsanguineous marriage presented with erythema, pigmentation, and roughness of the cheeks since early childhood. There is a history of burning sensation and an increase in the erythema on exposure to Sun. There is no similar history in any of his family members. He denied any application of topical medications except emollients. During childhood, he developed multiple depressed scars on the left side of face spontaneously. His caregivers denied any history of trauma to the affected area of face. There is no history of loss of hair from any part of the body. There is no history of blistering on exposure to sunlight. Physical examination of the patient showed erythema, brownish hyperpigmentation and keratotic follicular papules present on the cheeks, preauricular and submandibular areas in a bilaterally symmetrical distribution [ Figures 1 and 2] . On the left cheek, he had multiple atrophic scars in a linear and stellate pattern [ Figures 1 and 2 ]. In addition, there were multiple keratotic follicular papules present on the shoulders and extensor aspects of upper arms with perifollicular erythema at places [ Figure 3 ]. Examination of hair, nails, and mucous membranes was normal. Systemic examination was unremarkable. Biopsy of the skin was not performed. Based on history and further supported by clinical examination, a diagnosis of EFFC with atrophy was made. Since atrophy in EFFC has rarely been reported which inspired the author to report the same.
EFFC, though not so rare, has been rarely reported. It classically presents with well-defined Atrophy in erythromelanosis follicularis faciei et colli: Is it coincidence or association?
by honeycomb type of atrophic scars associated with keratotic papules. [7] However, a well-defined erythema and pigmentation in EFFC easily differentiates it from the former. Furthermore, the scars in the present case were not honeycomb type rather stellate or linear. Poikiloderma of civatte also comes under the differential diagnosis. It is usually seen in middle-aged women as erythema, reticulate dyschromia, and atrophy. It usually involves photoexposed areas and spares the submental region. However, the absence of follicular papules and late onset differentiates it from the EFFC with atrophy. [8] Thus, author concludes that atrophy can occur in EFFC which is distinct from simple KP with atrophy. However, more reports and studies are required to establish a definite association between the two.
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Late neonatal varicella
on injection acyclovir at a dose of 10 mg/kg/dose 8 hourly along with strict maintenance of hygiene. She showed crusting and substantial reduction of skin lesions by day 19 of her life [ Figure 1b ] and was discharged on exclusive breast feeds on day 21 after 7 days of intravenous acyclovir therapy.
Neonatal varicella occurs in babies of mothers who develop chickenpox during the last 3 weeks of pregnancy; the infection is usually transmitted from the mother to child by transplacental route, ascending infection during delivery, or by postnatal contact (respiratory droplet/direct). [1] The presentation of neonatal varicella depends on the time of maternal infection. If the mother develops rash on day 5 antepartum to day 2 postpartum, generalized neonatal varicella leading to death occurs in approximately one-fifth of cases. Neonatal chickenpox within the first 4 days after birth is usually mild. A fatal outcome has been reported in 23% of cases if neonatal chickenpox occurs between 5 and 10-12 days of age. If mother is symptomatic within 5 days before to 2 days after delivery, there is no time for transfer of varicella-associated antibody to the baby; thus, the baby has severe infection and usually it is fatal. If the mother has symptoms at least 5 days before delivery, the disease in infants is attenuated, as adequate maternal antibodies are transferred to the fetus. [1] Although, in our case, the mother was Sir, A 14-day-old newborn female baby was admitted with complaints of generalized polymorphic rashes over body for 3 days [ Figure 1a ]. She was born by normal vaginal delivery at home to a 30-year-old, second gravida mother at term gestation. The mother developed similar lesions 1 day before onset of labor. There was history of contact with her sister-in-law having similar illness. At presentation, the baby weighed 3.1 kg and had stable vital parameters. A clinical diagnosis of neonatal varicella was made and the baby was started 
